Skip to content

Public FDA record

Z-0996-2023: Vasoshield Syringe Packs, Model VH-5001

Recall record Z-0996-2023 for Maquet Cardiovascular, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0996-2023
Company in FDA record
Maquet Cardiovascular, LLC
FDA classification date
Jan 19, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Ink on the Vasoshield syringe Maquet logo may chip resulting in an unreasonable risk of harm to the patient. Potential harms may include foreign body reaction, coronary embolic event, and peripheral embolic event.

Source facts

Action
URGENT MEDICAL DEVICE Removal notification letters dated 12/22/22 were sent to customers. Actions to be taken by the Customer: Our records indicate that you have received the Hemopro 2 with Vasoshield and Vasoshield Syringe from lots affected by this recall. Please, note that Distributed Affected Lot Numbers appear on the device shelf boxes only. Please examine your inventory immediately to determine if you have any of Hemopro 2 with Vasoshield and/or Vasoshield Syringe with the product code/lot numbers listed in this notice. LOT numbers can be found on the product label in the area circled in red. 1. Should you have any affected product lots as listed in this notification, please stop using and remove the complete device from areas of use. Distributed Affected Lot Number can be found on the device package. 2. Should you have un-used affected VH-4001 kits and/or VH-5001 (partial or full packs) you are eligible for credit. 3. Please forward this information to all current and potential Hemopro 2 with Vasoshield and Vasoshield Syringe users within your hospital / facility. 4. If you are a distributor who has shipped any affected products to customers, please forward this document to their attention for appropriate action. 5. Please contact Getinge Customer Service at 888-880-2874 between the hours of 6:00 a.m. and 5:00 p.m. Pacific Standard Time to request a return authorization (RMA) and shipping instructions to return any affected product. 6. Whether you have affected product or not, please complete and sign the attached MEDICAL DEVICE Removal - RESPONSE FORM (page 4) to acknowledge that you have received this notification. Return the completed form to Maquet Cardiovascular, LLC /Getinge by e-mailing a scanned copy to Vasoshield2022.act@getinge.com or by faxing the form to (877)-804-2316. We apologize for any inconvenience this recall may cause. If you have any questions, please contact your Maquet Cardiovascular, LLC /Getinge representative or call the Geting
Initiated
2022-12-22
Root cause
Under Investigation by firm
Distribution
US Nationwide. Japan, Germany.
Recall number
Z-0996-2023
Recall status
Open, Classified
CDRH record ID
197574
FDA classified
2023-01-19
Recall event number
91363

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗